197379-70-7

Basic information

• Product Name: 6-broMo-1,4,4-triMethyl-1,2,3,4-tetrahydroquinoline
• Synonyms: 6-broMo-1,4,4-triMethyl-1,2,3,4-tetrahydroquinoline;6-bromo-1,4,4-trimethyl-2,3-dihydroquinoline
• CAS NO: 197379-70-7
• Molecular Formula: C12H16BrN
• Molecular Weight: 254.16614
• Mol File: 197379-70-7.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-broMo-1,4,4-triMethyl-1,2,3,4-tetrahydroquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 6-broMo-1,4,4-triMethyl-1,2,3,4-tetrahydroquinoline(197379-70-7)
• EPA Substance Registry System: 6-broMo-1,4,4-triMethyl-1,2,3,4-tetrahydroquinoline(197379-70-7)

Safety Data

• Hazardous Substances Data: 197379-70-7(Hazardous Substances Data)

Usage

Description

6-Bromo-1,4,4-trimethyl-1,2,3,4-tetrahydroquinoline is a quinoline derivative chemical compound characterized by the presence of a bromine atom and three methyl groups attached to the quinoline ring. It is a brominated derivative of 1,2,3,4-tetrahydroquinoline and is known for its unique chemical properties, making it a valuable building block in the synthesis of biologically active molecules.

Uses

Used in Pharmaceutical Industry:
6-Bromo-1,4,4-trimethyl-1,2,3,4-tetrahydroquinoline is used as a building block for the synthesis of various biologically active molecules. Its unique chemical properties, including the presence of a bromine atom, contribute to the development of new drugs and other organic compounds with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 6-bromo-1,4,4-trimethyl-1,2,3,4-tetrahydroquinoline serves as a versatile intermediate for the creation of a wide range of organic compounds. Its structural features allow for further functionalization and modification, enabling the synthesis of novel molecules with diverse applications.
Used in Medicinal Chemistry:
6-Bromo-1,4,4-trimethyl-1,2,3,4-tetrahydroquinoline is utilized in medicinal chemistry for the design and synthesis of new pharmaceutical agents. Its unique structural features and chemical properties make it a promising candidate for the development of innovative drugs with improved efficacy and selectivity in treating various diseases and medical conditions.

Upstream product

• 135631-90-2 4,4-dimethyl-6-bromo-2-oxo-1,2,3,4-tetrahydroquinoline 
• 135631-89-9 N-(3,3'-dimethylacryoloyl)-4-bromoaniline 
• 106-40-1 4-bromo-aniline 
• 3350-78-5 3,3-Dimethylacryloyl chloride 
• 77-78-1 dimethyl sulfate 
• 135631-91-3 6-bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline 

Relevant articles and documents

Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity

A series of retinoids, containing heteroatoms in a cyclic ring and called heteroarotinoids, were synthesized, and their biological activity was evaluated using tissue culture lines that have measurable responses to trans- retinoic acid (t-RA). Transglutam